Leadership Transition Recent leadership change with Tom KraMer stepping down and Fred Sklenar appointed as CEO signals potential new strategic direction and increased emphasis on design-driven development partnerships. Target opportunities with the new leadership to align on innovation roadmaps and refreshed go-to-market strategies.

Healthcare Design Strong legacy in medical device design and collaborations with Nonin Medical indicate ongoing demand for regulated, user-centric healthcare products. Sales opportunities exist in medical device development, compliance-ready UX, and robust housing for rugged environments.

End-to-End Capabilities Full-service offering spanning product research, design, and development with a Design Driven Development Process emphasizes end-to-end support. Position as a turnkey partner for clients facing bandwidth constraints or needing faster time-to-market with proven design processes.

Established Revenue Scale Reported revenue range of 25 to 50 million suggests meaningful project scopes and corporate stability. Approach mid-market and enterprise prospects seeking seasoned design firms capable of handling complex, multi-disciplinary programs.

Strategic Partnerships Past collaborations with industry players and a history of asset-based transitions through prior ownership indicate resilience and network depth. Leverage existing relationships and co-sell with complementary manufacturing or regulatory services to expand deal flow.